KIAA0027, which may be involved in catatonic schizophrenia (SCZD10, MIM 605419), is also likely to play a critical role in myelination and in diseases of the white matter, such as megalencephalic leukoencephalopathy with subcortical cysts (MLC, MIM 604004) . The potential function of KIA0027 in myelination is interesting in the light of the increasingly appreciated hypothesis that some forms of schizophrenia-like psychosis represent leukoencephalopathies or myelinopathies and that a variety of neurodegenerative disorders with a genetic, vascular, or inflammatory etiology that lead to white matter dysfunction and disrupted cortical-striatal-limbic connectivity can be associated with psychotic episodes.
REVIEW

Mouse genetic models for prepulse inhibition: an early review MA Geyer, KL McIlwain, R Paylor
The authors critically evaluate studies using murine genetic models to investigate prepulse inhibition of startle, a measure of sensorimotor-gating deficits in schizophrenia. Building on extensive human and rat studies of prepulse inhibition, work with genetically engineered mice has generated new insights into the genetics, neurobiology, and psychopharmacology of this robust cross-species form of information processing. The review also presages promising approaches using mouse models to extend this work.
IMMEDIATE COMMUNICATION
5-HT2A promoter polymorphism −1438G/A in children and adolescents with obsessive-compulsive disorders S Walitza, C Wewetzer, A Warnke, M Gerlach, F Geller, G Gerber, T Gö rg, B Herpertz Dahlmann, E Schulz, H Remschmidt, J Hebebrand, A Hinney An analysis of the promoter polymorphism −1438G/A of the 5-HT 2A -receptor gene in 55 children and adolescents with obsessive compulsive disorder (OCD) and in 223 controls exhibited a positive association between OCD and the A-allele. Both genotype and allele frequencies differed significantly between the groups. This is the first association study based on children and adolescents with OCD pertaining to this polymorphism. The authors conducted a retrospective association study on rhesus macaque infants homozygous for the long variant of the serotonin transporter gene regulatory region or heterozygous for the short and long form. Thirty-six mother-reared, and 79 nursery-reared monkeys were assessed during month 1 postnatal on a standardized primate infant neurobehavioral examination. Heterozygotes demonstrated more affective responding than homozygotes. Nursery-reared, but not motherreared, l/s infants exhibited lower orientation scores than l/l infants.
ORIGINAL RESEARCH ARTICLES
Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cm interval R Rademakers, M Cruts, B Dermaut, K Sleegers, SM Rosso, M Van den Broeck, H Backhovens, J van Swieten, CM van Duijn, C Van Broeckhoven The authors report the results of a genome-wide search in a four-generation pedigree with frontotemporal dementia characterized by dense ubiquitin-positive tau-negative neuronal inclusions. They identified a candidate region of 4.8 cM between D17S1787 and D17S958, containing MAPT, with a maximum multipoint LOD score of 5.51 at marker D17S951. Despite extensive mutation analysis, no MAPT mutations were detected. The authors suggest that the apparent absence of MAPT mutations combined with the lack of tau pathology is highly suggestive for another defective gene at 17q21 responsible for FTD in this family.
Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice R Xu, D Hranilovic, LA Fetsko, M Bucan, Y Wang
The authors investigated the role of dopamine D2L and D2S receptors in the mechanisms of action of clinically used dopaminergic drugs, using D2L knockout mice as a model. They found that D2L may play a prominent role in the motor side effects induced by typical antipsychotics, whereas D2S may have a greater impact on the therapeutic actions of atypical antipsychotics. These findings may provide novel insights for developing better antipsychotics.
Decreased muscarinic receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia B Dean, M McLeod, D Keriakous, J McKenzie, E Scarr
In this paper, the authors show that there is a decrease in muscarinic receptors but not muscarinic receptors in the prefrontal cortex from subjects with schizophrenia. This change was not present in another region of the cortex, not thought to be involved in the pathology of the disorder. These data argue that changes in the cholinergic system of the brain are involved in the pathology of schizophrenia. The authors examined whether variation within six genes from the VCFS critical region at 22q11 (DGSC, Stk22A1, DGSI, Gscl, Slc25A1 and Znf74) confers susceptibility to schizophrenia. Pooled genotyping revealed no significant differences in the allele frequencies for any polymorphism between cases and controls. In addition, they also attempted to define the location of a schizophrenia susceptibility locus by performing association mapping using seven microsatellites spanning the VCFS region. Marker D22S944 provided evidence for association in a sample of 368 cases and 368 controls and transmission disequilibrium in a further sample of 278 parent-proband trios.
Mutation screening and LD mapping in the VCFS
Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia R Miyatake, A Furukawa, H Suwaki
In this study, the authors determined the nucleotide sequence of the 5Ј-upstream region of the human NMDA receptor 2B (NR2B) subunit gene and identified a novel T-200G variant that appears to be significantly associated with schizophrenia. This variant has a marked effect on the NGF-induced expression of the NMDA2B gene. These findings suggest that this variant may be involved in glutamate dysfunction associated with the development of schizophrenia.
The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs YK Kim, IB Suh, H Kim, CS Han, CS Lim, SH Choi, J Licinio
Interleukin-12 (IL-12) is a pro-inflammatory cytokine that is produced primarily by monocyte and macrophage and plays a central role in promoting type I T helper cell-specific cellular immunity. The authors found that the IL-12 levels of major depression victims were significantly increased, with no difference in the occurrence of schizophrenia or bipolar mania. Moreover, IL-12 levels of the three patients groups were decreased significantly after 8 weeks of treatment. The authors suggest that the activation of an inflammatory response system, especially Th-1 like cells, would be related to the pathophysiology of major depression and repeated administration of antidepressant or antipsychotics would suppress IL-12 plasma levels in psychiatric patients.
Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders YWY Yu, SJ Tsai, TJ Chen, CH Lin, CJ Hong
The authors investigated inter-individual variations in response to SSRI treatment in a Chinese population and got a result in accordance with the other three studies performed on the western countries. They demonstrated an association between a better response to SSRI antidepressant and the 'long' allele of 5-HTTLPR, and accordingly refuted the argument that the association would vary with ethnic background.
Combined action of the ACE D and the G-protein ␤3
T allele in major depression: a possible link to cardiovascular disease? B Bondy, TC Baghai, P Zill, R Bottlender, M Jaeger, C Minov, C Schü le, P Zwanzger, R Rupprecht, RR Engel Although it is well established that depression is a major risk factor for the development of cardiovascular disease and that cerebrovascular disease may contribute to the development of depression, the underlaying pathophysiological mechanisms are not elucidated. As both disorders have a considerable genetically influenced susceptibility, genes or gene-gene interactions might be important for unravelling pathogenetic mechanisms of these multifactorial diseases. The authors investigated the angiotensin I converting enzyme (ACE) ID and the G-protein ␤3-subunit (G␤3) C825T polymorphisms in 201 patients with unipolar major depression and 161 controls. Both gene variants have earlier been associated with either cardiovascular disease or affective disorders, making them good candidates for a combined investigation. Their analysis show that the same allelic combination of the two genes that was earlier associated with myocardial infarction (ACE ID/DD-G␤3 TT genotype) also increases vulnerability for depressive disorder and might thus be one link for the interaction between both disorders.
Molecular Psychiatry
Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls H Ono, O Shirakawa, N Kitamura, T Hashimoto, N Nishiguchi, A Nishimura, H Nushida, Y Ueno, K Maeda Serotonergic dysfunction is thought to be involved in the biological pathogenesis of suicide. In this study, both tryptophan hydroxylase (TPH) immunoreactivity and serotonin receptor 2A (5HT2A) receptor density were measured in the prefrontal cortex of postmortem brains and no significant differences were found in these serotonergic markers between suicide victims and controls. This article also provides the first evidence that the AA genotype of the A218C polymorphism of the TPH gene showed higher TPH immunoreactivity along with lower 5HT2A receptor density than did any other genotypes.
